Analysis of 3-(4-hydroxy, 2-methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 918-925

  Meyer, Edwin M ^a   Kuryatov, Alexander ^a   Gerzanich, Volodymyr ^a   Lindstrom, Jon ^a   Papke, Roger L ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALPHA BUNGAROTOXIN; NICOTINIC RECEPTOR; 3 (4 HYDROXY 2 METHOXYBENZYLIDENE)ANABASEINE; 3-(2,4-DIMETHOXYBENZYLIDENE)ANABASEINE; 3-(4-HYDROXY-2-METHOXYBENZYLIDENE)ANABASEINE; ALPHA-BUNGAROTOXIN RECEPTOR; ANABASINE; BENZYLIDENE DERIVATIVE; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; DRUG DERIVATIVE; NICOTINIC AGENT; PYRIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL STRAIN; DRUG EFFICACY; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMORY; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; XENOPUS; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR CLONING; OOCYTE; SPECIES DIFFERENCE; XENOPUS LAEVIS;

ANABASINE; ANIMALS; BENZYLIDENE COMPOUNDS; BUNGAROTOXINS; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NICOTINIC AGONISTS; OOCYTES; PC12 CELLS; PYRIDINES; RATS; RECEPTORS, NICOTINIC; SPECIES SPECIFICITY; XENOPUS LAEVIS;

EID: 0032254325     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arendash GW, Sengstock GJ, Sanberg PR and Kern WR (1995) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259.
2. Azuma R, Minami Y and Satoh T (1996) Simultaneous determination of GTS-21 and its metabolite in rat plasma by high performance liquid chromatography using solid-phase extraction. J Chromatog Biomed Appl 686:229-234.
3. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliot RL, Gopalakrishnan M, Holladay M, Holladay W, Hui Y, Jackson W, Kirn DJB, Marsh KC, O'Neill AO, Pendergast MA, Ryther KB, Sullivan JP and Arneric SP (1997) Functional characterization of the novel nicotinic receptor ligand GTS-21 in vitro and in vivo. Pharm Biochem Behav 57:231-241.
4. Cafe C, Torri C, Bertorelli L, Angeretti N, Lucca E, Forloni G and Marzatico F (1996) Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures. Neurosci Lett 203:61-65.
5. Cheng YC and Prusoff WH (1997) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. Cotman CW (1997) The beta-amyloid peptide, peptide self-assembly, and the emergence of biological activities. A new principle in peptide function and the induction of neuropathology. Ann NYAcad Sei 814:1-16.
7. de Fiebre CM, Meyer EM, Zoltewicz J, Henry JC, Muraskin S, Kern WR and Papke RL (1995) Characterization of a family of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative (DMAC) is a selective ago-nist at neuronal nicotiriic a7/[12al]a-bungarotoxin receptor subtypes. Mol Pharmacol 47:164-171.
8. Fagarasam MO and Efthimiopoulos S (1996) Mechanism of amyloid beta-peptide (1-42) toxicity in PC12 cells. Mol Psychiatry 1:398-403.
9. Flores CM, Rogers SW, Pabreza LA, Wolfe BB and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharm 41:31-37.
10. Fukuyama R, Wadhwani KC, Galdzicki Z, Rapoport SI and Ehrenstein G (1994) Beta-amyloid polypeptide increases calcium uptake in PC 12 cells: A possible mechanism for its cellular toxicity in Alzheimer's disease. Brain Res 26:269-272.
11. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S and Lindstrom J ( 1995) Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharm 48:774-782.
12. Gopalakrishnan M, Buisson B, Tourna E, Giordano T, Campbell JE, Hu I, DonnellyRoberts D, Arneric SP, Bertrand D and Sullivan JP (1995) Stable expression and pharmacological properties of the human a 7 nicotinic acetylcholine receptor. Eur J Pharm 290:237-246.
13. Gray R, Rajan AS, Radcliffe KA, Yakehiro M and Dam JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713-716.
14. Hardy J ( 1997) The Alzheimer family of diseases: Many etiologies, one pathogenesis? Proc Natl Acad Sei USA 94:2095-2097.
15. Hunter BE, De Fiebre CM, Papke RL, Kem WR and Meyer EM (1994) A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168:130-134.
16. Kem WR, Mahnir VM, Lin B and Prokai-Tartrai K (1996) Two primary GTS-21 metabolites are potent partial agonists at alpha? nicotinic receptors expressed in the Xenopus oocyte. Soc Neurosci 26:268.
17. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T and Akaike A (1997) Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42:159-163.
18. Luetje CW and Patrick J (1991) Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845.
19. Mahnir V, Lin B, Prokai-Tatrai K and Kem WR (1998) Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing excretion. Biop-harm Drug Dispos 19:147-151.
20. Mandelzys A, De Koninck P and Cooper E (1995) Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple ACh receptor subunits. J Neurophys 74:1212-1221.
21. Marks MJ, Stitzel JA, Romm E, Wehner JM and Collins AC (1986) Nicotine binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine, and a-bungarotoxin. Mol Pharm 30:427-436.
22. Martin EJ, Panikar KS, King MA, Deyrup M, Hunter B, Wang G and Meyer E (1994) Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic cells. Drug Dev Res 31:134-141.
23. McGehee DS, Heath MJS, Gelber S, Devay P and Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696.
24. Meyer E, De Fiebre CM, Hunter B, Simpkins CE, Frauworth N and De Fiebre NC (1994) Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31:127-134.
25. Meyer EM, Tay ET, Papke RL, Meyers C, Huang G and De Fiebre CM (1997) Effects of 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) on rat nicotinic receptors and memory-related behaviors. Brain Res 768:49-56.
26. Meyer EM, King MA and Meyers C (1998a) Neuroprotective effects of 2,4dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Res 786:152-154.
27. Meyer EM, Tay ET, Zoltewicz JA, Meyers C, King MA, Papke RL and De Fiebre CM (1998b) Neuroprotective and memory-related actions of novel al nicotinic agents with different mixed agonist/antagonist properties. J Pharmacol Exp Ther 284: 1026-1032.
28. Mulle C, Lena C and Changeux J-P (1992) Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron 8:937-945.
29. Nakayama H, Nakashima T and Kurogochi Y (1991) o4 is a major acetylcholine binding subunit of cholinergic ligand affinity-purified nicotinic acetylcholine receptor form rat brains. Neurosci Lett 121:122-124.
30. Papke RL, Bencherif M and Lippiello P (1996) An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the a7 subtype. Neurosci Lett 213:201-204.
31. Papke RL and Heinemann SF (1991) The role of the 4 subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine a3-receptor. J Physiol 440:95-112.
32. Papke RL, Thinschmidt JS, Moulton BA, Meyer EM and Poirier A (1997) Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. Br J Pharmacol 120:429-438.
33. Sands SB, Costa ACS and Patrick JW (1993) Barium permeability of neuronal nicotinic acetylcholine receptor alpha 7 expressed in Xenopus oocytes. Biophys J 65:2614-2621.
34. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA and Patrick JW (1993) Molecular cloning, functional properties and distribution of rat brain alpha7: A nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
35. Shimohama S, Greenwald DL, Shafron DH, Akaike A, Maeda T, Kaneko S, Kimura J, Simpkins CE, Day AL and Meyer EM (1998) Nicotinic a 7 receptors protect against glutamate neurotoxicity and neuronal ischémie damage. Brain Res 779: 359-363.
36. Vernino S, Amador M, Luetje CW, Patrick J and Dani JA ( 1992) Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 8:127-134.
37. Whiting PJ and Lindstrom JM (1988) Characterization of bovine and human neuronal nicotinic acetylcholine receptors using mono clonal antibodies. J Neurosci 8:3395-3404.
38. Woodruff-Pak DS, Li Y and Kern WR (1994) A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317.
39. Zamani MR, Alien YS, Owen GP and Gray JA (1997) Nicotine modulates the neurotoxic effect of beta-amyloid protein (25-35) in hippocampal cultures. Neuroreport 8:513-517.
40. Zhang Z, Coggan JS and Berg DK (1996) Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin. Neuron 17:1231-1240.